
|Articles|June 1, 2003
- Volume 0 0
Reports form ACC 03: Advances in Lipid Management
Advertisement
Physicians, nurses, and other health care providers from the United States and around the world gathered in Chicago, March 30 to April 2, 2003, for the 52nd Annual Scientific Session of the American College of Cardiology. Identification of patients at high risk for cardiovascular disease, advances in lipid-lowering therapy, and modification of other cardiovascular risk factors were discussed at symposia and oral and poster sessions. Highlights of these sessions as well as a commentary on the clinical implications of these new findings are presented here.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants National Priority Vouchers to Enlicitide Decanoate, Sacituzumab Tirumotecan
2
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
3
Toothpaste Tablets Are Gaining Popularity—Here’s Where Pharmacists Fit In
4
Twists, Turns, and Tapers: Navigating the Benzodiazepine Ride
5













































































































































































































